Luoxin group (Stock code: 002793) is one of the leading pharmaceutical companies in China, which is engaged in pharmaceutical research & development, manufacturing, sales and healthcare service. Luoxin group focuses on the area of oncology, respiratory diseases, antibiotics, cardiovascular disease, digestive disease essential for human health. And certification with EU GMP, Philippine GMP, PIC/S GMP. At present, Luoxin Group has five production sites that include Luoxin workshop, Yuxin workshop, Hengxin crude material branch, Lekang Traditional Chinese Medicine branch and Luoxin Aurovitas BFS branch. With more than 50 production lines of powder injection, freeze-dried powder injection, solid preparation (including cephalosporin), spray, aerosol, pre-filled, large-capacity injection, small-capacity injection, atomized inhalation, chemical API, cephalosporin API and so on. More than 300 products of more than a dozen dosage forms have been put on the market. Warmly welcome to contact us and look forward to building a long-term business relationship with you in recent future!